share_log

6-K: Gsk Announces Positive Phase Iii Results from Anchor Trials for Depemokimab in Chronic Rhinosinusitis with Nasal Polyps

6-K: Gsk Announces Positive Phase Iii Results from Anchor Trials for Depemokimab in Chronic Rhinosinusitis with Nasal Polyps

6-K:GSK宣布积极的III期depemokimab的ANCHOR试验结果慢性鼻-鼻窦炎伴有鼻息肉
美股SEC公告 ·  10/15 06:18
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息